Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment-Reference-Cited by-同舟云学术

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

Published:2005-10 Issue:1 Volume:162 Page:57-62
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Galimberti Sara,Cervetti Giulia,Guerrini Francesca,Testi Rossana,Pacini Simone,Fazzi Rita,Simi Paolo,Petrini Mario

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference23 articles.

1. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

2. Effects of a selective inhibitor of ABL tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

3. ARG tyrosine kinase activity is inhibited by STI571;Okuda;Blood,2001

4. Gleevec (imatinib mesylate) induces hematologic and cytogenetic responses confirmed and expanded in patients with chronic myeloid leukemia (CML) – a phase II study update;Kantarjian;Blood,2001

5. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study;Talpaz;Blood,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population;Cancer Chemotherapy and Pharmacology;2024-06-18

2. The Oncogenic Protein, Breakpoint Cluster (BCR)-Abelson Kinase (ABL) and Chronic Myelocytic Leukemia (CML): Insight Into the Drug Resistance Mechanisms and Approaches for Targeting BCR-ABL in CML;Reference Module in Biomedical Sciences;2021

3. Downregulation of MDR 1 gene contributes to tyrosine kinase inhibitor induce apoptosis and reduction in tumor metastasis: A gravity to space investigation;International Journal of Pharmaceutics;2020-12

4. Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance;Mini-Reviews in Medicinal Chemistry;2019-01-29

5. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia;Mechanisms of Drug Resistance in Cancer Therapy;2017-12-15